A positron emission tomography (PET) – computed tomography (CT) is an advanced nuclear medicine technique that uses a single gantry to acquire sequential images of the body using a PET scanner and an X-ray computed tomography scanner. Essentially, it reveals critical details about the structure and role of cells and tissues in the body during a single imaging session.
The majority of PET scans have recently been conducted on instruments that combine PET and CT scanners. PET is a form of imaging that combines nuclear medicine and biochemistry. PET is a form of imaging that is used to image physiological changes in the body, such as the metabolism of the heart muscle. It is most widely used in patients with brain or heart disorders, as well as cancer.
Doctors may use a PET scan to search for diseases in your body. A special dye containing radioactive tracers is used in the scan. Depending on part of the body under investigation, these tracers are swallowed, inhaled, or inserted into a vein in your arm. The tracer is then absorbed by specific organs and tissues. The tracers help to see how well your organs and tissues are functioning when they are identified by a PET scanner.
The tracer can accumulate in areas with higher chemical activity, which is beneficial since many body tissues and diseases have higher levels of chemical activity. On a PET scan, these diseased areas will appear as bright spots. The PET scan will determine blood flow, oxygen intake, sugar metabolism, and other factors.
Key Drivers for PET-CT Scanner Device Market
The global PET-CT scanner device market growth is driven by a rise in the incidence of diseases such as Alzheimer, cancer, HIV, and cardiovascular diseases. Also, the growth of the geriatric population that is more susceptible to take medications for ensuring better health is expected to fuel the market growth.
The imaging technology of the PET-CT scanner provides accurate staging & localization, early detection, and precise monitoring of the diseases. Thereby, providing patients a better glance at disease detection, treatment outcome, as well as avoid unnecessary procedures. These factors are anticipated to boost the PET-CT scanner device market growth in the future.
Major Regional Trends Observed in Recent Years
Asia Pacific dominated the PET-CT scanner device market, followed by North America. Asia is expected to be the fastest-growing regional market. The rise in the pool of patient population, the prevalence of infectious and chronic diseases, and government investments in the creation of improved healthcare facilities and R&D activities are all contributing to the overall growth of the market. Owing to the increasing focus of key players in emerging economies is creating a positive environment for the PET-CT scanner device market.
Competitive Landscape of PET-CT Scanner Device Market
Key manufacturers operating from different parts of the world are introducing new PET/CT designs. New technology enables more accurate measurements of metabolic processes and data quantification, such as neurologic disease assessment, cancerous tissue assessment, and cardiac blood flow assessment. Product launch is a primary development strategy for players in this market. Furthermore, the market’s sales growth is aided by the production of newer products and the rise in investment for R&D programs.
Some of the prominent players profiled in the PET-CT scanner device market are Hitachi, Ltd., PerkinElmer, Inc., Toshiba Corporation, Mediso Ltd., Koninklijke Philips N.V., Yangzhou Kindsway Biotech Co. Ltd, Siemens AG, General Electric Co., and Positron Corporation. Gallium 68 PSMA-11 (Ga 68 PSMA-11) has received approval from the FDA for positron emission tomography (PET) imaging of PSMA-positive lesions in men with prostate cancer (PCa).
Deep-dive Insights on PET-CT Scanner Device Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/pet-ct-scanner-device-market/request-for-sample